2,6-Bis-acetaminobenzo <1,2-d:4,5-d'> bis-thiazol;2,6-bis-acetylamino-benzo[1,2-d;4,5-d']bisthiazole;Cambridge id 6041674;N-(2-acetamido-[1,3]thiazolo[5,4-f][1,3]benzothiazol-6-yl)acetamide
The present invention encompasses compounds of general formula (1) wherein R
1
, M
1
, L
1
and Q are defined as in claim
1
, which are suitable for the treatment of diseases characterised by excessive or anomalous cell proliferation, and the use thereof for preparing a pharmaceutical composition with the above-mentioned properties.